ImPACT Applications Launches First Pediatric Medical Device for Concussion Management

By: ImPACT News

ImPACT Applications announces ImPACT Pediatric, its newest innovation in the field of concussion management. The first and only FDA-approved concussion-specific tool designed for individuals ages 5-11, ImPACT Pediatric provides health care professionals with objective measures of neurocognitive functioning for evaluation and management of concussion in younger children. 

ImPACT Pediatric is an iPad-based computerized test that is individually administered, engaging for children, and easy to use in a clinical setting. It addresses a gap that has existed in the medical device community for years—a lack of normed and validated computerized neurocognitive assessment tools for efficiently and effectively measuring neurocognitive function in this age group. Created by ImPACT Applications, the developer of the FDA-approved ImPACT® computerized neurocognitive concussion assessment and management tool, ImPACT Pediatric offers pediatric patients the same advantages seen by more than 10 million ImPACT test takers.